Association of Age at Onset and First Symptoms With Disease Progression in Patients With Metachromatic Leukodystrophy
Christiane Kehrer(University Children's Hospital Tübingen), Samuel Groeschel(University of Tübingen), Judith Böhringer(University Children's Hospital Tübingen), Stefanie Beck‐Wödl(University of Tübingen), Ingeborg Krägeloh‐Mann(University Children's Hospital Tübingen), Nadja Kaiser(University Children's Hospital Tübingen), Lüdger Schöls(German Center for Neurodegenerative Diseases), Christa Raabe(University Children's Hospital Tübingen), Andrea Bevot(University Children's Hospital Tübingen), Saskia Elgün(University of Tübingen)
Cited by 94
Related Papers
Autosomal dominant cerebellar ataxias: clinical features, genetics, and pathogenesis
|The Lancet Neurology|2004|1.1k
Clinical features, neurogenetics and neuropathology of the polyglutamine spinocerebellar ataxias type 1, 2, 3, 6 and 7
|Progress in Neurobiology|2013|360
Human multipotent mesenchymal stromal cells use galectin-1 to inhibit immune effector cells
|Blood|2010|265
Deep Intronic <i>FGF14</i> GAA Repeat Expansion in Late-Onset Cerebellar Ataxia
|New England Journal of Medicine|2022|243